Anixa Biosciences Inc

ANIX Nasdaq SEC CIK 715446
Follow Anixa Biosciences Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Net income −$2.6M −15.4% vs same quarter last year
EPS, diluted −$0.08 −14.3% vs same quarter last year
Operating cash flow −$1.8M −17.1% vs same quarter last year
Operating income −$2.7M −12.4% vs same quarter last year
Net income by quarter
−$2.9M
−$3.2M
−$2.8M
−$2.3M
−$2.7M
−$2.6M
−$2.5M
−$2.6M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$20M−$10M$0$10MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25-−$10.9M
FY24$210K−$12.6M
FY23$210K−$9.8M
FY22--
FY21$512K−$13M
FY20-−$10M
FY19$250K−$11.6M
FY18$1.1M−$14M
FY17$362.5K−$5M
FY16$300K−$5M
FY15$9.3M−$1.4M
FY14$3.7M−$9.6M
FY13$388.9K−$10.1M
FY12$940K−$4.3M
FY11$1M−$7.4M
MarginsShare of revenue
  • Operating margin
  • Net margin
−8000%−6000%−4000%−2000%0%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearOperating marginNet margin
FY25--
FY24−6586.2%−5978.1%
FY23−5243.3%−4671.9%
FY22--
FY21−2565.6%−2530.1%
FY20--
FY19−4756%−4658.8%
FY18−1284.4%−1258.1%
FY17−1676%−1381.8%
FY16−1503%−1672.1%
FY15−10.2%−14.9%
FY14−137.5%−261.9%
FY13−2036.2%−2592.3%
FY12−439.8%−452.4%
FY11−501.2%−735.5%
Free cash flowOperating cash flow minus capital expenditure
−$8M−$6M−$4M−$2M$0$2MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25-
FY24-
FY23-
FY22-
FY21-
FY20−$6.2M
FY19−$4.9M
FY18−$4.3M
FY17−$3.8M
FY16−$3.5M
FY15$1.3M
FY14−$2.4M
FY13-
FY12−$3.1M
FY11−$725K
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Anixa Biosciences
  • Healthcare median
−6000%−4000%−2000%0%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearAnixa BiosciencesHealthcare median
FY25-−30.6%
FY24−5978.1%−47%
FY23−4671.9%−58%
FY22-−80.4%
FY21−2530.1%−71.8%
FY20-−62.2%
FY19−4658.8%−46.2%
FY18−1258.1%−49.6%
FY17−1381.8%−45.9%
FY16−1672.1%−36%
FY15−14.9%−37.8%
FY14−261.9%−35.5%
FY13−2592.3%−37.1%
FY12−452.4%−29.1%
FY11−735.5%−27.9%